Dr Robert Wayne Thompson Jr, MD | |
11005 W 60th St Ste 210, Shawnee, KS 66203-2789 | |
(913) 631-7700 | |
(913) 631-8080 |
Full Name | Dr Robert Wayne Thompson Jr |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 27 Years |
Location | 11005 W 60th St Ste 210, Shawnee, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366432361 | NPI | - | NPPES |
200004910A | Medicaid | KS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 0429611 (Kansas) | Primary |
Entity Name | Thompson Eye Clinic, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164574117 PECOS PAC ID: 4789786021 Enrollment ID: O20070216000531 |
News Archive
Based on the Action Plan 2012, Evotec decided in March 2009 to strengthen its discovery alliances, creating the central vehicle for growth, and to implement strict cost cutting and restructuring measures. The Company reduced headcount in administrative and clinical development functions, reprioritised its R&D activities, concentrated its operations in Europe and closed the former facility of Renovis, Inc. in South San Francisco.
In a significant advance toward understanding a perplexing and painful neurological disorder, an international team of researchers has discovered gene mutations associated with an inherited chronic pain and weakness syndrome known as hereditary neuralgic amyotrophy (also called HNA).
Synapses are the sites that connect neurons – sites where information is passed from one neuron to another. They are highly specialized structures and synaptic function is crucial for normal brain function.
A groundbreaking new study led by the University of Kentucky Markey Cancer Center's Dr. Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain - providing insight into potential therapeutic targets to treat the aggressive cancer.
YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today announced that it has priced an underwritten public offering of 25,000,000 common shares at a price to the public of $1.60 per share.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Robert Wayne Thompson Jr, MD 11005 W 60th St Ste 210, Shawnee, KS 66203-2789 Ph: (913) 631-7700 | Dr Robert Wayne Thompson Jr, MD 11005 W 60th St Ste 210, Shawnee, KS 66203-2789 Ph: (913) 631-7700 |
News Archive
Based on the Action Plan 2012, Evotec decided in March 2009 to strengthen its discovery alliances, creating the central vehicle for growth, and to implement strict cost cutting and restructuring measures. The Company reduced headcount in administrative and clinical development functions, reprioritised its R&D activities, concentrated its operations in Europe and closed the former facility of Renovis, Inc. in South San Francisco.
In a significant advance toward understanding a perplexing and painful neurological disorder, an international team of researchers has discovered gene mutations associated with an inherited chronic pain and weakness syndrome known as hereditary neuralgic amyotrophy (also called HNA).
Synapses are the sites that connect neurons – sites where information is passed from one neuron to another. They are highly specialized structures and synaptic function is crucial for normal brain function.
A groundbreaking new study led by the University of Kentucky Markey Cancer Center's Dr. Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain - providing insight into potential therapeutic targets to treat the aggressive cancer.
YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today announced that it has priced an underwritten public offering of 25,000,000 common shares at a price to the public of $1.60 per share.
› Verified 8 days ago
Dr. William Albert Pilchard, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 14629 W 49th Terrace, Shawnee, KS 66216 Phone: 913-825-0052 | |
Dr. Aaron R Florkowski, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 21620 Midland Dr, Ste B, Shawnee, KS 66218 Phone: 913-787-6724 Fax: 913-273-1210 | |
Charles Richard Ford, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4742 Black Swan Drive, Shawnee, KS 66216 Phone: 913-268-0265 Fax: 913-768-8210 |